Skip to main content
PROTEOME SCIENCES PLC logo

PROTEOME SCIENCES PLC — Investor Relations & Filings

Ticker · PRM ISIN · GB0003104196 LEI · 213800Q62ICXANKU2986 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2021-04-14 Director's Dealing
Country GB United Kingdom
Listing IL PRM

About PROTEOME SCIENCES PLC

https://www.proteomics.com/

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 4746V' and contains language typical of regulatory announcements on the London Stock Exchange's RNS system, including references to 'UK Market Abuse Regulation'. The core content details a 'Director/PDMR Shareholding' transaction, specifically a purchase of Ordinary Shares by the Chief Commercial Officer. This type of insider transaction report is explicitly covered by the 'Director's Dealing' definition. The document structure and content strongly align with Form DIRS (Director's Dealing) filings, which are often disseminated via RNS.
2021-04-14 English
Second Price Monitoring Extn
Capital/Financing Update Classification · 1% confidence The document is very short (1936 chars) and contains the header 'RNS Number : 7329U' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, non-standard regulatory market announcement. Since it is a direct, short announcement from the exchange's news service (RNS) about a market event rather than a comprehensive report (like 10-K, IR, ER), it fits best under the general regulatory announcement category, RNS, which serves as a fallback for miscellaneous regulatory filings.
2021-04-07 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and contains information about an extension of the auction call period for a security, which is a standard market operation announcement. The text concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, DIRS). Since it is a general regulatory announcement that doesn't fit the other specific categories, the fallback category 'Regulatory Filings' (RNS) is the most appropriate classification.
2021-04-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number' and contains the standard structure of a regulatory notification disseminated via RNS (Regulatory News Service). Specifically, the form is titled 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification as MRQ over the general RNS fallback.
2021-04-01 English
Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is an RNS announcement dated April 1, 2021, from Proteome Sciences PLC. The key content is the announcement that the CEO will provide a live presentation relating to the Company's results for the year ended 31 December 2020 via the Investor Meet Company platform. This is an announcement about an upcoming investor event/presentation, not the presentation itself, nor is it the full annual report (10-K) or the earnings release (ER). The description explicitly mentions an 'Investor Presentation' event. Therefore, the most appropriate classification is Investor Presentation (IP). Although it is distributed via RNS, the specific content points directly to IP.
2021-04-01 English
Final Results
Earnings Release Classification · 1% confidence The document is an 'Earnings Release' (ER). It is titled 'Final results for the year ended 31 December 2020' and contains key financial highlights (revenues, costs, profit, cash reserves) and management commentary. While it mentions that the full Annual Report will be posted later, this document itself provides the substantive financial results for the period, fitting the definition of an Earnings Release rather than a mere publication announcement. FY 2020
2021-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.